Acute generalized exanthematous pustulosis (AGEP) and psoriasis: what can be learned from co-morbidities. A comparative study


04 Apr 2019 10:16 Ricerca


BACKGROUND:

Acute generalized exanthematous pustulosis (AGEP) is a rare pustular severe cutaneous adverse reaction. Differentiating between AGEP and pustular psoriasis may represent a diagnostic challenge. We sought to evaluate the prevalence of co-morbidities in a series of patients with AGEP compared to a series of patients with psoriasis vulgaris and to a series of patients with drug related psoriasis.

METHODS:

Medical records of 14 patients with AGEP, 33 patients with psoriasis vulgaris, and 18 patients with drug-related psoriasis were reviewed. The presence of co-morbidities was recorded, and a comparative analysis was performed.

RESULTS:

A personal history of psoriasis was present in 4 (28%) patients with AGEP compared to 12 (66%) patients with drug-related psoriasis (Pv=0.03). The prevalence of psoriasis-related morbidities was significantly lower in the AGEP group compared to the psoriasis group and to the drug-related psoriasis group (Pv<0.01, 0.05, respectively). Each of the psoriasis-related morbidities had significantly lower prevalence in the AGEP group compared to the psoriasis group and to the drug-related psoriasis group (Pv<0.01).

CONCLUSIONS:

In conclusion, differences between AGEP, psoriasis vulgaris, and drug related psoriasis regarding the prevalence of psoriasis-related morbidities may assist differentiation in borderline cases.

Inserito da segreteria SIDeMaST

Approfondimenti

FonteGiornale Italiano Dermatologia Venereologia
Titolo originaleAcute generalized exanthematous pustulosis (AGEP) and psoriasis: what can be learned from co-morbidities. A comparative study
AutoriGuy SHALOM, Batya B. DAVIDOVICI, Amir HOREV, Sima HALEVY
Link fonteLink articolo originale
Argomenti correlati psoriasi

SIDeMaST è su Facebook

Segui la pagina e diffondi la cultura dermatologica condividendo i contenuti.

Ti è piaciuto questo contenuto?